Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 Diabetes

The Sim-Q demonstrated good reliability and validity in this psychometric study. This measure may be useful for assessing individuals' perceptions of treatment simplicity in clinical trials and clinical practice.

Authors

Institutions

Publication Details

Journal
Advances in Therapy
Published
2026-02-12
DOI
https://doi.org/10.1007/s12325-025-03448-5
Primary Topic
Diabetes Management and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 Diabetes

Louis S. Matza, Karin S. Coyne, Katelyn Cutts, Kristina S. Boye
Advances in Therapy
Diabetes Management and Education
article

Psychometric Validation of the Simplicity of Diabetes Treatment Questionnaire (Sim-Q) for Type 2 Diabetes

Louis S. Matza, Karin S. Coyne, Katelyn Cutts, Kristina S. Boye
article en

Abstract

The Sim-Q demonstrated good reliability and validity in this psychometric study. This measure may be useful for assessing individuals' perceptions of treatment simplicity in clinical trials and clinical practice.

Advances in Therapy
Eli Lilly (United States) (US), Thermo Fisher Scientific (United States) (US)
Good health and well-being
Openalex Percentile: Top 60%
Diabetes Management and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.